Having trouble finding Budesonide/Formoterol (Symbicort) at your pharmacy? Learn why this inhaler is hard to find in 2026 and what you can do about it.
You depend on your Budesonide/Formoterol inhaler to breathe. So when you show up at the pharmacy and hear "we don't have it right now," it can feel like a punch to the gut. If this has happened to you recently, you're not imagining things — and you're definitely not alone.
Budesonide/Formoterol, sold under the brand name Symbicort and as the generic Breyna, has been one of the harder-to-find inhalers over the past few years. While the situation has improved heading into 2026, many patients still run into availability problems depending on where they live and which pharmacy they use.
Let's break down what's going on and what you can do about it.
Budesonide/Formoterol is a combination inhaler used to treat asthma (in patients 6 years and older) and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It combines two active ingredients:
Together, they help prevent asthma attacks and COPD flare-ups when used regularly. It's important to note that Budesonide/Formoterol is not a rescue inhaler — it's a maintenance medication you take every day, usually two puffs twice daily.
The inhaler comes in two strengths: 80/4.5 mcg and 160/4.5 mcg. Both brand-name Symbicort (made by AstraZeneca) and generic versions are available as metered-dose inhalers (MDIs).
There are several reasons this medication can be difficult to locate at your local pharmacy. Here are the biggest factors:
The pharmaceutical supply chain took a major hit during and after the pandemic. Inhaler manufacturing is particularly complex — it involves pressurized canisters, precise metering valves, and specialized propellants. Even small disruptions at manufacturing facilities can ripple across the supply for months.
While things have improved significantly since the worst shortages in 2023–2024, some regions still experience intermittent gaps in supply.
Asthma and COPD affect tens of millions of Americans. Budesonide/Formoterol is one of the most commonly prescribed combination inhalers in the country. When supply tightens even slightly, the sheer volume of prescriptions can quickly outpace what pharmacies have on their shelves.
Even when the manufacturer is shipping product, wholesalers (the middlemen between drug makers and pharmacies) sometimes place limits on how much each pharmacy can order. This means your pharmacy might want to stock more Budesonide/Formoterol but physically can't get enough from their distributor.
Insurance companies periodically change which inhalers they prefer to cover. When a large insurer moves Budesonide/Formoterol to a preferred position on their formulary, demand can spike at pharmacies overnight, creating temporary shortages before supply catches up.
The good news is you have options. Here's what to try:
Medfinder lets you search for pharmacies near you that currently have Budesonide/Formoterol in stock. Instead of calling pharmacy after pharmacy, you can check availability online and save yourself time and stress.
Big chain pharmacies tend to get hit hardest by allocation limits. Independent pharmacies sometimes have more flexibility with their wholesaler relationships and may have stock when CVS or Walgreens doesn't. It's worth making a few calls.
If you truly cannot find Budesonide/Formoterol, talk to your prescriber about alternative medications like Advair (Fluticasone/Salmeterol), Breo Ellipta, or Dulera. These are all ICS/LABA combination inhalers that work similarly.
If your pharmacy is out of brand-name Symbicort, ask about the generic version — Breyna or authorized generic budesonide/formoterol. Generics are often easier to find and significantly cheaper, sometimes as low as $90–$150 with a discount card.
Don't wait until your inhaler is completely empty. Most insurance plans allow you to refill a few days before you run out. Building in a buffer gives you time to search if your usual pharmacy is temporarily out of stock.
The overall trend is positive. The entry of generic Budesonide/Formoterol (Breyna) into the market has increased the total supply available. The FDA has also been actively working with manufacturers to address inhaler supply issues.
That said, localized shortages can still pop up, especially during respiratory illness season (fall and winter) when demand peaks. Staying proactive about your refills is the best defense.
Not being able to find a medication you need to breathe is genuinely frightening. But understanding why it's happening — and knowing your options — can make a huge difference.
If you're struggling to locate Budesonide/Formoterol, start by checking real-time pharmacy stock on Medfinder, ask about generic alternatives, and talk to your doctor if you need to switch. You don't have to navigate this alone.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
